XML 52 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)
12 Months Ended
Jun. 30, 2016
Quarterly Financial Information Disclosure [Abstract]  
Schedule of quarterly financial data
Summarized quarterly data for fiscal years 2016 and 2015 follows:
 
 
Quarter Ended
 
 
 
 
September 30
 
December 31
 
March 31(a)
 
June 30(a)
 
Year Ended
 
 
(Dollars in thousands, except per share amounts)
2016
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
450,130

 
$
450,467

 
$
442,565

 
$
447,707

 
$
1,790,869

Cost of service and product revenues, excluding depreciation and amortization
 
260,804

 
267,056

 
260,046

 
259,623

 
1,047,529

Operating income (loss)
 
4,276

 
(2,883
)
 
5,621

 
10,600

 
17,614

Net (loss) income(b)
 
(808
)
 
(13,986
)
 
(2,084
)
 
5,562

 
(11,316
)
Net (loss) income per basic and diluted share(d)
 
(0.02
)
 
(0.29
)
 
(0.04
)
 
0.12

 
(0.23
)
 
 
Quarter Ended
 
 
 
 
September 30
 
December 31
 
March 31
 
June 30
 
Year Ended
 
 
(Dollars in thousands, except per share amounts)
2015
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
464,551

 
$
455,887

 
$
453,960

 
$
462,889

 
$
1,837,287

Cost of service and product revenues, excluding depreciation and amortization
 
268,664

 
268,049

 
261,947

 
264,615

 
1,063,275

Operating (loss) income
 
(754
)
 
(671
)
 
5,402

 
(446
)
 
3,531

Loss from continuing operations(b)
 
(9,843
)
 
(16,663
)
 
(4,763
)
 
(1,943
)
 
(33,212
)
Loss from discontinued operations(c)
 

 

 

 
(630
)
 
(630
)
Net loss(b)(c)
 
(9,843
)
 
(16,663
)
 
(4,763
)
 
(2,573
)
 
(33,842
)
Loss from continuing operations per share, basic and diluted(d)
 
(0.18
)
 
(0.30
)
 
(0.09
)
 
(0.04
)
 
(0.60
)
Loss from discontinued operations per share, basic and diluted
 

 

 

 
(0.01
)
 
(0.01
)
Net loss per basic and diluted share(d)
 
(0.18
)
 
(0.30
)
 
(0.09
)
 
(0.05
)
 
(0.62
)
_______________________________________________________________________________
(a)
During the third quarter of fiscal year 2016, the Company recorded a cumulative adjustment to correct prior period errors that related to the overstatement of interest expense, insurance expense and telephone expense, and the understatement of depreciation expense in prior periods. The impact of these items on the Company's Consolidated Statement of Operations decreased interest expense by $0.6 million, decreased site operating expenses by $0.5 million, increased depreciation expense by $0.3 million, and decreased net loss by $0.8 million. During the fourth quarter of fiscal year 2016, the Company recorded an adjustment to correct an error related to the overstatement of depreciation expense in prior periods. The impact of this item on the Company's Consolidated Statement of Operations decreased depreciation expense and net loss by $1.1 million. Because these errors were not material to the Company's consolidated financial statements for any prior periods, the respective quarter, or fiscal year, the Company recorded adjustments to correct the errors during each respective quarter for fiscal 2016.
(b)
During the second quarter of fiscal year 2016, the Company recorded a $13.0 million other than temporary impairment charge on its investment in EEG. During the second quarter of fiscal year 2015, the Company recorded a $4.7 million other than temporary impairment charge and $6.9 million of its share of a deferred tax valuation allowance on its investment in EEG.
(c)
During the fourth quarter of fiscal year 2015, the Company recorded expenses of $0.6 million in discontinued operations related to legal fees related to Trade Secret.
(d)
Total is an annual recalculation; line items calculated quarterly may not sum to total.